BridgeMD
New treatment option for Cerebral Palsy
Official title Effects of Hand and Arm Bimanual Intensive Therapy Including Lower Extremity in Spastic Cerebral Palsy
ClinicalTrials.gov ID: NCT07253857
What this study is testing
- What it's testing
- Cerebral palsy (CP), particularly the spastic diplegic subtype, is characterized by motor impairments such as spasticity and mobility limitations. In addition to motor dysfunction, children with CP often experience cognitive impairments affecting decision-making, problem-solving, working memory, selective attention, and inhibitory control.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12
You may be able to join if
- Diagnosed with diplegic cerebral palsy
- CP children with manual ability level 1-3 on manual ability classification system
- Participants with gross motor function classification system level ranging from 1-3 will be included in the study.
- With an ability to grasp light objects and lift the more affected arm 15 cm above a table surface.
- Base line cognition level should be 20 or above assessed through mini mental state exam for children (MMC).
You likely can't join if
- Uncontrolled seizures
- Recent or planned botulinum toxin injections within 6 months
- Any recent orthopedic interventions that may affect motor function
- Visual impairments impeding with treatment protocol
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.